2025-05-17 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data, presented in English with key numbers and analysis:

## Colgate-Palmolive (CL) Stock Analysis

Colgate-Palmolive Co. manufactures and markets household, health care, and personal care products worldwide.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 24.84%
*   **VOO Cumulative Return:** 84.12%
*   **Absolute Deviation:** -59.28% (CL underperformed VOO)
*   **Relative Deviation:** 7.6 (Indicates CL's underperformance is near the bottom of its historical range relative to VOO)

**Analysis:** Colgate-Palmolive has significantly underperformed the S&P 500 over the period. The relative deviation suggests that this underperformance is at the lower end of its historical range, but still represents a substantial gap.

### 2. Alpha, Beta Analysis

Here's the table and analysis:

| Year       | CAGR   | MDD    | Alpha    | Beta   | Cap(B) |
|------------|--------|--------|----------|--------|--------|
| 2015-2017  | 13.0%  | 4.8%   | -16.0%   | 0.1    | 51.2   |
| 2016-2018  | -11.0% | 65.2%  | -29.0%   | 0.1    | 41.4   |
| 2017-2019  | 7.0%   | 65.2%  | -22.0%   | 0.2    | 49.1   |
| 2018-2020  | 18.0%  | 65.2%  | -8.0%    | 0.7    | 62.4   |
| 2019-2021  | 30.0%  | 58.6%  | -25.0%   | 1.0    | 63.7   |
| 2020-2022  | 8.0%   | 69.0%  | 1.0%     | 1.0    | 60.2   |
| 2021-2023  | 8.0%   | 69.0%  | -9.0%    | 0.9    | 62.5   |
| 2022-2024  | 15.0%  | 69.0%  | -2.0%    | 0.8    | 72.8   |
| 2023-2025  | 11.0%  | 72.8%  | -21.0%   | 0.3    | 73.9   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate fluctuates significantly over the periods, indicating varying performance.
*   **MDD:** The Maximum Drawdown is high in some periods (e.g., 65.2% - 72.8%), showing significant potential losses.
*   **Alpha:** Consistently negative alpha values suggest underperformance relative to the market risk-free rate.
*   **Beta:** Beta values are low (0.1 to 1.0), indicating lower volatility than the market.
*   **Cap(B):** Market Cap is consistently increasing.

### 3. Recent Stock Price Movements

*   **Current Price:** $91.23
*   **Previous Close:** $89.63
*   **Change:** $1.79 (Positive Change)
*   **5-Day Moving Average:** $89.09
*   **20-Day Moving Average:** $91.32
*   **60-Day Moving Average:** $91.48

**Analysis:** The stock price increased from the previous close. The 5-day moving average is below the current price, suggesting a short-term upward trend. However, the current price is slightly below both the 20-day and 60-day moving averages, potentially indicating resistance at these levels.

### 4. Market Risk Indicator and Expected Return

*   **Market Risk Indicator (MRI):** 0.3475 (Low Risk)
*   **RSI:** 51.25 (Neutral)
*   **PPO:** -0.20 (Neutral)
*   **20-Day Relative Deviation Change:** -12.2 (Short-term decline)
*   **Expected Return:** -459.9% (Significantly negative - indicates potential underperformance vs. S&P 500 over a longer investment horizon)

**Analysis:**

*   The MRI indicates low market risk.
*   RSI is close to 50, indicating a neutral market sentiment.
*   The negative PPO suggests the stock price is below its moving average, which could indicate a potential downtrend.
*   The recent negative change in relative deviation aligns with the short-term downward trend.
*   The significantly negative expected return is concerning, suggesting potential long-term underperformance compared to the S&P 500.
*   Given the positive change in price from the last market, it reflects a recent surge in the stock price. This upward trend is noteworthy, but it needs to be examined in the context of the longer-term indicators to understand its sustainability.

### 5. Recent News & Significant Events

*   Volatility influenced by recent news, earnings reports, or executive actions.
*   Analysts discussing performance and outlook in the context of industry and global economics.
*   Market experts highlighting risks and opportunities, advising monitoring of news and announcements.
*   Made headlines due to major business developments, regulatory changes, or market events.

**Analysis:**  Recent news suggests the stock is experiencing volatility and is subject to analyst scrutiny due to industry trends and economic factors. Monitoring news and announcements is crucial.

### 6. Recent Earnings Analysis

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-04-25 | 0.85 | 4.91 B$    |
| 2024-10-25 | 0.90 | 5.03 B$    |
| 2024-07-26 | 0.89 | 5.06 B$    |
| 2024-04-26 | 0.83 | 5.07 B$    |
| 2025-04-25 | 0.83 | 5.07 B$    |

**Analysis:** Revenue is declining over the past few quarters, while EPS is fluctuating. The most recent EPS is slightly higher than the prior year, but the revenue is lower. This requires further investigation to understand the reasons for the decline in revenue and how the company is managing profitability.

### 7. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $4.91B   | 60.82%        |
| 2024-12-31   | $4.95B   | 60.30%        |
| 2024-09-30   | $5.03B   | 61.08%        |
| 2024-06-30   | $5.06B   | 60.62%        |
| 2024-03-31   | $5.07B   | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-03-31   | $0.36B   | 190.08%    |
| 2024-12-31   | $0.21B   | 348.58%    |
| 2024-09-30   | $0.43B   | 169.43%    |
| 2024-06-30   | $0.12B   | 594.31%    |
| 2024-03-31   | $0.23B   | 296.96%    |

**Analysis:**

*   **Revenue:** Similar to the earnings data, revenue shows a declining trend over the quarters.
*   **Profit Margin:** Profit margins are relatively stable around 60%, which is positive.
*   **Equity:** Equity fluctuates.
*   **ROE:** Return on Equity is exceptionally high but also volatile. High ROE may not be sustainable and should be investigated further. This volatility indicates underlying financial instability and needs to be examined for long-term sustainability.

### 8. Overall Analysis

Colgate-Palmolive (CL) is currently showing mixed signals.

*   **Negative Signs:** The company has significantly underperformed the S&P 500, has a negative expected return, and is experiencing declining revenue.  The alpha values consistently point to underperformance. High ROE may not be sustainable and should be investigated further.
*   **Positive Signs:**  The company maintains a low market risk profile, stable profit margins, and has recently experienced a stock price increase.
*   **Neutral Signs:** RSI and PPO are within a neutral range.

**Recommendation:**  Given the long-term underperformance, declining revenue, and volatile financial metrics, a cautious approach is warranted. While the recent stock price increase and low market risk are positive, they are outweighed by the negative indicators. It would be best to monitor the company's performance closely, analyze future earnings reports, and consider the industry trends before making any investment decisions. The high ROE numbers need to be scrutinized to understand their sustainability. It's essential to understand the reasons for the revenue decline and how the company plans to address it.
